Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Wesley Stotler

Foot and Ankle Surgery Tulsa, OK Doctor of Osteopathy

NPI 1013984251 CMS profile 137128

4802 S 109Th East Ave, Tulsa, OK 74146

Open in the dashboard

General payments

$267,604

163 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Wesley Stotler of Tulsa, OK is reported in the CMS Open Payments database as having received $267,604 across 163 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Foot and Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $36,231 41
2024 General $6,700 12
2023 General $18,003 19
2022 General $44,551 14
2021 General $90,242 27
2020 General $30,216 8
2019 General $41,663 42

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Wesley Stotler
  • Foot and Ankle Surgery median
  • Middle half of Foot and Ankle Surgery
  • National median

In program year 2025, general payments to Wesley Stotler were reported at $36,231. Among 650 Foot and Ankle Surgery profiles paid that year, the median was $1,183 and the middle half received between $267 and $6,309.

Show as a table
Year Wesley Stotler Foot and Ankle Surgery median Middle half National median
2019 $41,663 $1,327 $279–$5,421 $163
2020 $30,216 $795 $121–$3,473 $114
2021 $90,242 $1,289 $201–$4,963 $132
2022 $44,551 $1,539 $270–$6,067 $149
2023 $18,003 $1,117 $257–$5,264 $160
2024 $6,700 $1,064 $235–$4,944 $164
2025 $36,231 $1,183 $267–$6,309 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Exactech, Inc. $78,051 54 payments
  2. MedShape, Inc. $60,114 2 payments
  3. Medartis Inc. $41,636 15 payments
  4. Nextremity Solutions Inc. $36,840 5 payments
  5. Crossroads Extremity Systems, LLC $19,496 19 payments
  6. Djo, LLC $8,996 9 payments
  7. Extremity Medical $8,008 7 payments
  8. Ortho Solutions Inc $6,851 17 payments
  9. Medical Device Business Services, Inc. $4,050 2 payments
  10. Pylant Medical $1,284 9 payments
  11. Other $2,276 24 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $107,295 50 payments
  2. Royalty or License $83,785 20 payments
  3. Acquisitions $60,077 1 payment
  4. Travel and Lodging $8,062 16 payments
  5. Food and Beverage $5,808 74 payments
  6. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,760 1 payment
  7. Education $816 1 payment
Products named General payments · program years 2019–2025
  1. APTUS Ortho $38,482 10 payments
  2. EQUINOXE $27,765 18 payments
  3. VANTAGE Orthopaedic $18,511 7 payments
  4. VANTAGE Orthopaedic $16,322 12 payments
  5. Medical Implant $11,596 16 payments
  6. LCP $4,135 4 payments
  7. NA $4,135 4 payments
  8. APTUS Ortho $2,484 4 payments
  9. TRULIANT $1,760 1 payment
  10. EPIC FOOT PLATE SYSTEM $1,527 3 payments
  11. Other $3,379 34 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

548

Median for Orthopedic Surgery: 203

Drug cost

$4,831

Median for Orthopedic Surgery: $1,433

Branded share of claims

66.2%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 273 $2,316
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 64 $713
Cephalexin Generic 45 $543
Clindamycin Hcl Generic 14 $451
Rifampin Generic 12 $300
Meloxicam Generic 60 $203
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim Brand 26 $158
Tramadol Hcl Generic 54 $148

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 79 billing codes

Paid by Medicare

$143,776

Medicare's payments for the services billed

Medicare patients

398

Average age 72

Services billed

1,811

264 women, 134 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 73%
Depression 24%
Ischemic heart disease 23%
Diabetes 22%
Osteoporosis 20%
Chronic kidney disease 17%
Atrial fibrillation 14%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

163 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Foot and Ankle Surgery in Oklahoma

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record